Sugammadex Injection, Solution
Product Images NDC 42677-311

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 42677-311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Shandong New Time Pharmaceutical Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2 mL Carton (2 mL Carton)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) solution for intravenous use. The label indicates 10 single-dose 2 mL vials, is marked Rx only, and includes the manufacturer Shandong New Time Pharmaceutical Co., Ltd. The label also features the NDC 42677-311-10 and the NTP logo.*

FDA Label Image

2 mL Container (2 mL Container)

Label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) in a 2 mL single-dose vial for intravenous use. The sterile, non-pyrogenic aqueous solution is supplied by Shandong New Time Pharmaceutical Co., Ltd. The label includes storage instructions at 25°C, protection from light, and barcode.*

FDA Label Image

5 mL Carton (5 mL Carton)

Packaging label for Sugammadex Injection 500 mg/5 mL (100 mg/mL), an intravenous solution injection. The label indicates it is Rx only, supplied as 10 single-dose 5 mL vials, and is manufactured by Shandong New Time Pharmaceutical Co., Ltd. The NDC code 42677-312-10 is also displayed.*

FDA Label Image

5 mL Container (5 mL Container)

Label for Sugammadex Injection, 500 mg/5 mL (100 mg/mL) in a 5 mL single-dose vial. It is indicated for intravenous use only and is a sterile, non-pyrogenic aqueous solution. The label states storage at 25°C (77°F) and protection from light. Manufactured by Shandong New Time Pharmaceutical Co., Ltd., China. Includes a barcode and area to peel off and apply to syringe.*

FDA Label Image

Figure1 (Figure1)

A cumulative recovery rate graph showing time to recovery in minutes for three treatments: rocuronium plus sugammadex 2 mg/kg, sugammadex 2 mg/kg alone, and neostigmine 0.05 mg/kg. The chart compares median recovery times with rocuronium plus sugammadex and neostigmine, illustrating faster recovery with sugammadex treatments.*

FDA Label Image

Figure2 (Figure2)

A cumulative recovery rate survival plot comparing sugammadex 2 mg/kg and neostigmine 0.05 mg/kg over time to recovery in minutes. It includes median recovery times with quartile ranges for sugammadex (2.1 mg/kg) and neostigmine, showing censored observations and medians with quartiles based on product-limit estimates.*

FDA Label Image

Strcture-1 (Strcture 1)

Chemical structure diagram of sugammadex, depicting its molecular configuration with labeled atoms and bonds typical of the active pharmaceutical ingredient.*

FDA Label Image

Strcture-2 (Strcture 2)

Chemical structure of the active ingredient Sugammadex, showing its complex cyclic molecular arrangement with multiple hydroxyl (OH) groups and sodium carboxylate (CO2Na) moieties.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.